Close Menu

This article has been updated to clarify the FDA's request to labs.

NEW YORK – The American Clinical Laboratory Association (ACLA) yesterday issued a letter to the US Food and Drug Administration urging the agency to reconsider its recent actions against laboratories, asking them to change the way they matket pharmacogenetic (PGx) testing and report results.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.